AGÕæÈ˹ٷ½

STOCK TITAN

Agilent Technologies Inc SEC Filings

A NYSE

Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Agilent Technologies� filings rarely read like a simple story—they combine life-science breakthroughs, diagnostic regulations, and consumables economics in hundreds of pages. If you have ever tried to trace chromatography margins across segments or confirm executive stock sales before a product launch, you know the challenge.

Stock Titan’s AI-powered analysis turns that complexity into clarity. Whether you need the Agilent Technologies quarterly earnings report 10-Q filing to gauge consumables growth or an Agilent Technologies proxy statement executive compensation breakdown to benchmark R&D incentives, our platform delivers concise, plain-English takeaways the moment the document hits EDGAR. AGÕæÈ˹ٷ½-time alerts surface Agilent Technologies Form 4 insider transactions so you can monitor management moves without scrolling through PDF tables. Material developments? Our AI tags each Agilent Technologies 8-K material events explained note and links it to prior guidance.

Here’s how professionals use this page:

  • Track Agilent Technologies insider trading Form 4 transactions and spot buying or selling trends by lab-equipment executives.
  • Compare segment revenue, backlog, and China exposure across successive Agilent Technologies annual report 10-K simplified summaries.
  • Dive into cash-flow forecasts with our AI annotations inside every Agilent Technologies earnings report filing analysis.

Stop parsing technical jargon line by line. With Stock Titan you’re understanding Agilent Technologies SEC documents with AI—from real-time Agilent Technologies Form 4 insider transactions to deep-dive 10-K footnotes—in minutes, not days.

Filing
Rhea-AI Summary

Agilent Technologies (A) has filed a Form 144 covering a proposed sale of 2,000 common shares—valued at $226,900—through Fidelity Brokerage on or after 01 Aug 2025. With 284,064,728 shares outstanding, the notice equates to roughly 0.0007 % of the float, signalling no dilution risk or material impact on daily volume.

The securities were obtained via restricted-stock vesting on 14 Nov 2023 (compensation). The same holder sold 1,508 shares for $177,099.52 on 01 Jul 2025. Rule 144 certification states the seller is unaware of undisclosed adverse information.

Because Form 144 is a pre-trade notice rather than a binding order, actual execution, price, or quantity may differ. Overall, the filing reflects routine insider liquidity activity and offers limited fundamental insight into Agilent’s operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) filed an 8-K disclosing that Chief Financial Officer Robert W. McMahon will resign effective 31 July 2025. The company states the departure is not linked to any disagreement over accounting, financial statements, internal controls, or operations.

The board has appointed Rodney Gonsalves—currently Vice President, Corporate Controller and Principal Accounting Officer—as interim CFO and Principal Financial Officer, also effective 31 July 2025. Gonsalves will retain his existing positions, and the filing notes no related-party transactions requiring disclosure under Regulation S-K Item 404(a).

A press release announcing the leadership change was issued on 15 July 2025 and furnished as Exhibit 99.1. Apart from the management transition, the filing contains no financial updates, guidance revisions, or strategic transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
current report
Rhea-AI Summary

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU’s public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 4 Overview � Extra Space Storage Inc. (EXR)

EVP & Chief Strategy & Partnerships Officer William N. Springer reported a Code F transaction on 01 July 2025. Code F indicates the issuer withheld shares to cover taxes generated by the vesting of restricted stock rather than an open-market sale.

  • Shares withheld: 138 common shares at an implied price of $150.50.
  • Purpose: Satisfy payroll-tax obligations related to restricted stock that vested (25% per year over four years).
  • Post-transaction holding: 20,020 EXR shares held directly.

The withholding represents <0.01 % of EXR’s ~210 million outstanding shares and around 0.7 % of Springer's personal stake. Because no discretionary sale or purchase occurred, the filing is generally viewed as neutral from a market-signal perspective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Enterprise Bancorp Inc. (EBTC) � Form 4 insider filing

Director Carole A. Cowan reported the disposition of her entire 27,395.6835-share holding of EBTC common stock on 07/01/2025. The transaction was coded “D� because it was executed automatically at the closing of the previously announced merger between Enterprise Bancorp and Independent Bank Corp. Under the Merger Agreement, each EBTC share converted into (i) $2.00 cash and (ii) 0.60 shares of Independent common stock, with cash paid in lieu of fractional shares. The filing shows zero EBTC shares remaining in Cowan’s direct ownership, confirming that all unvested restricted shares vested and were included in the conversion.

The form contains no derivative securities activity and no subsequent EBTC ownership. The transaction reflects completion of the merger rather than discretionary trading, and therefore has limited standalone market impact beyond confirming the deal’s consummation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Summary

Agilent Technologies Inc. (symbol: A) has filed a Form 144, signaling the intention to sell 1,508 shares of its common stock, valued at roughly $177,099.52. The shares, originally received through restricted-stock vesting on 11/14/2023, are planned to be sold on or around 07/01/2025 via Fidelity Brokerage Services LLC on the NYSE. With 284,064,728 shares outstanding, the proposed sale represents less than 0.001% of total shares, indicating a de-minimis effect on the company’s share structure. The filer reported no other sales in the past three months and certified that no undisclosed material adverse information is known.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Insider Trading Alert: Agilent Technologies (NYSE: A) Director Judy L. Brown reported a sale of 7.76 shares of Common Stock on June 18, 2025, at a price of $116.533 per share. Following the transaction, Brown retains direct ownership of 1,677 shares.

Key Transaction Details:

  • Transaction was executed through a managed account where the reporting person lacks investment discretion
  • Filing was submitted via attorney-in-fact Shirley Qin on June 23, 2025
  • Transaction was reported as a direct ownership disposition (Form Code: S)

This relatively small insider sale represents a minor adjustment to the director's holdings and was executed through a managed account structure, suggesting it may be part of a broader portfolio management strategy rather than a significant directional bet on the company's prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

This Form 4/A filing amends a previous Form 4 for Judy L. Brown, a Director at Agilent Technologies. The amendment corrects the beneficial ownership information from a transaction dated May 21, 2025.

Key details of the filing:

  • Brown acquired 1,677 shares of common stock at $108.91 per share as part of a Non-Employee Director stock award
  • The shares were fully vested upon grant
  • The amendment adds 7.76 shares that were inadvertently omitted from the original filing
  • These additional shares were held in a managed account without Brown's investment discretion
  • Total beneficial ownership following the transaction: 1,684.76 shares (Direct Ownership)

The amendment was filed to ensure complete disclosure of all beneficially owned shares, including those in managed accounts, as required by SEC regulations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Agilent Technologies director Judy L. Brown filed an amended Form 3/A on June 28, 2025, correcting her initial beneficial ownership statement from May 23, 2025. The amendment discloses 7.76 shares of common stock that were previously omitted from the original filing.

Key details of the amendment:

  • The shares were held in a managed account where Brown lacked investment discretion
  • Brown was unaware of these shares at the time of the original Form 3 filing
  • The ownership form is listed as Direct (D)
  • The amendment was signed by Shirley Qin as attorney-in-fact for Brown on June 23, 2025

This Form 3/A ensures compliance with SEC regulations requiring disclosure of beneficial ownership by directors under Section 16(a) of the Securities Exchange Act of 1934. The correction, while minor in terms of share quantity, demonstrates proper regulatory compliance and transparency in insider ownership reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $113.52 as of August 1, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 33.5B.

What is the primary business model of Agilent Technologies Inc?

Agilent operates by delivering advanced analytical instruments, integrated software, consumables, and technical services that address the full spectrum of laboratory needs.

Which industries benefit most from Agilent's solutions?

Agilent’s solutions are widely used in biopharmaceutical research, environmental testing, clinical diagnostics, academic studies, and forensic science among other sectors.

How does Agilent support its customers in laboratory settings?

The company offers integrated lab management solutions, including robust data analysis software, maintenance services, and technical support to ensure maximum operational efficiency.

How has Agilent evolved since its foundation?

Spun out from Hewlett-Packard, Agilent has grown into a comprehensive life science and diagnostic firm that continuously adapts its product and service offerings to meet evolving laboratory challenges.

What makes Agilent's analytical instruments unique?

Agilent's instruments stand out due to their precision, integration with advanced software, and the ability to streamline complex laboratory workflows from sample preparation to data interpretation.

How does Agilent maintain its competitive position in the market?

Agilent differentiates itself by offering end-to-end laboratory solutions that combine equipment, software, and services, which provides customers with a seamless and integrated workflow.

What type of technological innovation drives Agilent's product development?

Agilent invests heavily in research and development, focusing on advancing analytical technologies and integrating cutting-edge data management solutions to enhance laboratory efficiency.

In which geographic regions is Agilent Technologies most active?

Agilent operates in multiple regions worldwide, with significant market presence in the United States, China, and other key global markets, ensuring wide-reaching service and product availability.
Agilent Technologies Inc

NYSE:A

A Rankings

A Stock Data

33.53B
283.14M
0.29%
91.65%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
United States
SANTA CLARA